The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II, dose escalation and dose expansion study of valemetostat tosylate (DS-3201b) with atezolizumab and bevacizumab in advanced hepatocellular carcinoma (HCC).
 
Mehmet Akce
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Curio Science; Curio Science; Daiichi Sankyo, Inc.; Dava Oncology; Eisai; Eisai; Eisai; Eisai; Eisai; Exelixis; Genentech; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; IDEOlogy Health; Incyte; Ipsen; Isofol Medical; MDoutlook; OncLive/MJH Life Sciences; Partner Therapeutics; QED Therapeutics; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb-Ono Pharmaceutical (Inst); Eisai (Inst); Eisai (Inst); Genentech (Inst); IMPAC Medical Systems (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Polaris (Inst); ProDa (Inst); RedHill Biopharma (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst); Xencor (Inst)
 
Charity Morgan
No Relationships to Disclose
 
Ahmet Ozluk
No Relationships to Disclose
 
S. M. Qasim Hussaini
No Relationships to Disclose
 
Garima Gupta
Stock and Other Ownership Interests - Abbott Laboratories; CUE Biopharma; IIPR; Moderna Therapeutics; Roche
 
Darryl Outlaw
No Relationships to Disclose
 
Alexander Bray
Stock and Other Ownership Interests - Procter & Gamble
 
Midhun Malla
Consulting or Advisory Role - AstraZeneca; BillionToOne; BMS; do moore; Exelixis; Incyte; Ipsen; Natera
Travel, Accommodations, Expenses - ESMO GI
 
Bassel El-Rayes
Consulting or Advisory Role - Pfizer
Research Funding - Adaptimmune (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); IQvia (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Wayne State University (Inst); Xencor (Inst); Zymeworks (Inst)